- call +1-201-465-4211
- email sales@mrinsights.biz
Market Overview
The global Next-Generation Sequencing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Next-Generation Sequencing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Next-Generation Sequencing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Next-Generation Sequencing market has been segmented into:
Targeted Sequencing & Resequencing
Whole Genome Sequencing
Whole Exome Sequencing
By Application, Next-Generation Sequencing has been segmented into:
Oncology
Hereditary Disease Detection
Life Science
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Next-Generation Sequencing market presented in the report. This section sheds light on the sales growth of different regional and country-level Next-Generation Sequencing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Next-Generation Sequencing market.
The report offers in-depth assessment of the growth and other aspects of the Next-Generation Sequencing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Next-Generation Sequencing Market Share Analysis
Next-Generation Sequencing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Next-Generation Sequencing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Next-Generation Sequencing sales, revenue and market share for each player covered in this report.
The major players covered in Next-Generation Sequencing are:
BGI
Genotypic Technology
Eurofins Scientific
Illumina
Qiagen
Perkinelmer
Dna Link
Macrogen
Gatc Biotech
Genewiz
Takara
Personalis
Scigenom Labs
Novogene
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Next-Generation Sequencing Market Overview
1.1 Product Overview and Scope of Next-Generation Sequencing
1.2 Classification of Next-Generation Sequencing by Type
1.2.1 Global Next-Generation Sequencing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Next-Generation Sequencing Revenue Market Share by Type in 2019
1.2.3 Targeted Sequencing & Resequencing
1.2.4 Whole Genome Sequencing
1.2.5 Whole Exome Sequencing
1.3 Global Next-Generation Sequencing Market by Application
1.3.1 Overview: Global Next-Generation Sequencing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Oncology
1.3.3 Hereditary Disease Detection
1.3.4 Life Science
1.4 Global Next-Generation Sequencing Market by Regions
1.4.1 Global Next-Generation Sequencing Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Next-Generation Sequencing (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Next-Generation Sequencing Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Next-Generation Sequencing Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Next-Generation Sequencing Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Next-Generation Sequencing Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Next-Generation Sequencing Status and Prospect (2015-2025)
2 Company Profiles
2.1 BGI
2.1.1 BGI Details
2.1.2 BGI Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 BGI SWOT Analysis
2.1.4 BGI Product and Services
2.1.5 BGI Next-Generation Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.2 Genotypic Technology
2.2.1 Genotypic Technology Details
2.2.2 Genotypic Technology Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Genotypic Technology SWOT Analysis
2.2.4 Genotypic Technology Product and Services
2.2.5 Genotypic Technology Next-Generation Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.3 Eurofins Scientific
2.3.1 Eurofins Scientific Details
2.3.2 Eurofins Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Eurofins Scientific SWOT Analysis
2.3.4 Eurofins Scientific Product and Services
2.3.5 Eurofins Scientific Next-Generation Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.4 Illumina
2.4.1 Illumina Details
2.4.2 Illumina Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Illumina SWOT Analysis
2.4.4 Illumina Product and Services
2.4.5 Illumina Next-Generation Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.5 Qiagen
2.5.1 Qiagen Details
2.5.2 Qiagen Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Qiagen SWOT Analysis
2.5.4 Qiagen Product and Services
2.5.5 Qiagen Next-Generation Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.6 Perkinelmer
2.6.1 Perkinelmer Details
2.6.2 Perkinelmer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Perkinelmer SWOT Analysis
2.6.4 Perkinelmer Product and Services
2.6.5 Perkinelmer Next-Generation Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.7 Dna Link
2.7.1 Dna Link Details
2.7.2 Dna Link Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Dna Link SWOT Analysis
2.7.4 Dna Link Product and Services
2.7.5 Dna Link Next-Generation Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.8 Macrogen
2.8.1 Macrogen Details
2.8.2 Macrogen Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Macrogen SWOT Analysis
2.8.4 Macrogen Product and Services
2.8.5 Macrogen Next-Generation Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.9 Gatc Biotech
2.9.1 Gatc Biotech Details
2.9.2 Gatc Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Gatc Biotech SWOT Analysis
2.9.4 Gatc Biotech Product and Services
2.9.5 Gatc Biotech Next-Generation Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.10 Genewiz
2.10.1 Genewiz Details
2.10.2 Genewiz Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Genewiz SWOT Analysis
2.10.4 Genewiz Product and Services
2.10.5 Genewiz Next-Generation Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.11 Takara
2.11.1 Takara Details
2.11.2 Takara Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Takara SWOT Analysis
2.11.4 Takara Product and Services
2.11.5 Takara Next-Generation Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.12 Personalis
2.12.1 Personalis Details
2.12.2 Personalis Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Personalis SWOT Analysis
2.12.4 Personalis Product and Services
2.12.5 Personalis Next-Generation Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.13 Scigenom Labs
2.13.1 Scigenom Labs Details
2.13.2 Scigenom Labs Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Scigenom Labs SWOT Analysis
2.13.4 Scigenom Labs Product and Services
2.13.5 Scigenom Labs Next-Generation Sequencing Revenue, Gross Margin and Market Share (2018-2019)
2.14 Novogene
2.14.1 Novogene Details
2.14.2 Novogene Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Novogene SWOT Analysis
2.14.4 Novogene Product and Services
2.14.5 Novogene Next-Generation Sequencing Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Next-Generation Sequencing Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Next-Generation Sequencing Players Market Share
3.2.2 Top 10 Next-Generation Sequencing Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Next-Generation Sequencing Revenue and Market Share by Regions
4.2 North America Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
4.3 Europe Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
4.5 South America Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
5 North America Next-Generation Sequencing Revenue by Countries
5.1 North America Next-Generation Sequencing Revenue by Countries (2015-2020)
5.2 USA Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
5.3 Canada Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
5.4 Mexico Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
6 Europe Next-Generation Sequencing Revenue by Countries
6.1 Europe Next-Generation Sequencing Revenue by Countries (2015-2020)
6.2 Germany Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
6.3 UK Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
6.4 France Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
6.5 Russia Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
6.6 Italy Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Next-Generation Sequencing Revenue by Countries
7.1 Asia-Pacific Next-Generation Sequencing Revenue by Countries (2015-2020)
7.2 China Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
7.3 Japan Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
7.4 Korea Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
7.5 India Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
8 South America Next-Generation Sequencing Revenue by Countries
8.1 South America Next-Generation Sequencing Revenue by Countries (2015-2020)
8.2 Brazil Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
8.3 Argentina Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Next-Generation Sequencing by Countries
9.1 Middle East & Africa Next-Generation Sequencing Revenue by Countries (2015-2020)
9.2 Saudi Arabia Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
9.3 UAE Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
9.4 Egypt Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
9.5 South Africa Next-Generation Sequencing Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Next-Generation Sequencing Revenue and Market Share by Type (2015-2020)
10.2 Global Next-Generation Sequencing Market Forecast by Type (2019-2024)
10.3 Targeted Sequencing & Resequencing Revenue Growth Rate (2015-2025)
10.4 Whole Genome Sequencing Revenue Growth Rate (2015-2025)
10.5 Whole Exome Sequencing Revenue Growth Rate (2015-2025)
11 Global Next-Generation Sequencing Market Segment by Application
11.1 Global Next-Generation Sequencing Revenue Market Share by Application (2015-2020)
11.2 Next-Generation Sequencing Market Forecast by Application (2019-2024)
11.3 Oncology Revenue Growth (2015-2020)
11.4 Hereditary Disease Detection Revenue Growth (2015-2020)
11.5 Life Science Revenue Growth (2015-2020)
12 Global Next-Generation Sequencing Market Size Forecast (2021-2025)
12.1 Global Next-Generation Sequencing Market Size Forecast (2021-2025)
12.2 Global Next-Generation Sequencing Market Forecast by Regions (2021-2025)
12.3 North America Next-Generation Sequencing Revenue Market Forecast (2021-2025)
12.4 Europe Next-Generation Sequencing Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Next-Generation Sequencing Revenue Market Forecast (2021-2025)
12.6 South America Next-Generation Sequencing Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Next-Generation Sequencing Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
List of Tables
Table 1. Global Next-Generation Sequencing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Next-Generation Sequencing by Company Type (Tier 1, Tier 2 and Tier 3)
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
